Astragaloside IV regulates differentiation and induces apoptosis of activated CD4+ T cells in the pathogenesis of experimental autoimmune encephalomyelitis
Author:
Funder
National Natural Science Foundation of China
Shanghai Eastern Scholar Program
Shanghai Youth Eastern Scholar Program
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference59 articles.
1. Low dose naltrexone therapy in multiple sclerosis;Agrawal;Med. Hypotheses,2005
2. Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely;Baker;Mult. Scler. Relat. Disord.,2014
3. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice;Bettelli;J. Immunol.,1998
4. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7;Bielekova;J. Neuroimmunol.,1999
5. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand;Bielekova;Nat. Med.,2000
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Huangqi-Guizhi-Wuwu decoction regulates differentiation of CD4+ T cell and prevents against experimental autoimmune encephalomyelitis progression in mice;Phytomedicine;2024-03
2. Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence;Phytomedicine;2024-01
3. Early Growth Response Gene-1 Deficiency Interrupts TGFβ1 Signaling Activation and Aggravates Neurodegeneration in Experimental Autoimmune Encephalomyelitis Mice;Neuroscience Bulletin;2023-09-19
4. Predicting the anti-inflammatory mechanism of Radix Astragali using network pharmacology and molecular docking;Medicine;2023-09-01
5. Nose to brain delivery of Astragaloside IV by β-Asarone modified chitosan nanoparticles for multiple sclerosis therapy;International Journal of Pharmaceutics;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3